Detection of TMPRSS2-ERG Translocations in Human Prostate Cancer by Expression Profiling Using GeneChip Human Exon 1.0 ST Arrays  Sameer Jhavar, Alison.

Slides:



Advertisements
Similar presentations
Development of a Novel One-Tube Isothermal Reverse Transcription Thermophilic Helicase-Dependent Amplification Platform for Rapid RNA Detection James Goldmeyer,
Advertisements

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
EGFR Mutations in Lung Adenocarcinomas
Detection of Exon 12 Mutations in the JAK2 Gene
Mutation Screening of EXT1 and EXT2 by Denaturing High-Performance Liquid Chromatography, Direct Sequencing Analysis, Fluorescence in Situ Hybridization,
Ane Y. Schmidt, Thomas v. O. Hansen, Lise B
Effectiveness of Capillary Electrophoresis Using Fluorescent-Labeled Primers in Detecting T-Cell Receptor γ Gene Rearrangements  Timothy C. Greiner, Ronald.
Detection of TMPRSS2-ETS Fusions by a Multiprobe Fluorescence in Situ Hybridization Assay for the Early Diagnosis of Prostate Cancer  Qi-Peng Sun, Liao-Yuan.
Genes with Bimodal Expression Are Robust Diagnostic Targets that Define Distinct Subtypes of Epithelial Ovarian Cancer with Different Overall Survival 
Statistical Considerations for Immunohistochemistry Panel Development after Gene Expression Profiling of Human Cancers  Rebecca A. Betensky, Catherine.
Tracy I. George, Joanna E. Wrede, Charles D. Bangs, Athena M
Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data  Catherine Grasso, Timothy Butler, Katherine Rhodes, Michael.
Haley J. Abel, Hussam Al-Kateb, Catherine E. Cottrell, Andrew J
Bead Array–Based microRNA Expression Profiling of Peripheral Blood and the Impact of Different RNA Isolation Approaches  Andrea Gaarz, Svenja Debey-Pascher,
In Silico Proficiency Testing for Clinical Next-Generation Sequencing
Detection of TMPRSS2-ETS Fusions by a Multiprobe Fluorescence in Situ Hybridization Assay for the Early Diagnosis of Prostate Cancer  Qi-Peng Sun, Liao-Yuan.
Microarray-Based Comparative Genomic Hybridization Using Sex-Matched Reference DNA Provides Greater Sensitivity for Detection of Sex Chromosome Imbalances.
The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients
Michael D. Onken, Lori A. Worley, Rosa M. Dávila, Devron H. Char, J
Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing  Jean-Marc Rey, Vincent Ducros, Pascal.
Precision Profiling and Components of Variability Analysis for Affymetrix Microarray Assays Run in a Clinical Context  Thomas M. Daly, Carmen M. Dumaual,
Β-Glucuronidase Is an Optimal Normalization Control Gene for Molecular Monitoring of Chronic Myelogenous Leukemia  Joong Won Lee, Qiaofang Chen, Daniel.
Jacek Majewski  The American Journal of Human Genetics 
Wanlong Ma, Hagop Kantarjian, Xi Zhang, Chen-Hsiung Yeh, Zhong J
Influence of RNA Labeling on Expression Profiling of MicroRNAs
RET Proto-Oncogene Genotyping Using Unlabeled Probes, the Masking Technique, and Amplicon High-Resolution Melting Analysis  Rebecca L. Margraf, Rong Mao,
Multiplex Ligation-Dependent Probe Amplification
Christopher R. Cabanski, Vincent Magrini, Malachi Griffith, Obi L
Comparative Genomic Hybridization Analysis of Astrocytomas
Molecular Diagnosis in Ewing Family Tumors
Carol S. Trempus, Hong Dang, Margaret M
A Tumor Sorting Protocol that Enables Enrichment of Pancreatic Adenocarcinoma Cells and Facilitation of Genetic Analyses  Zachary S. Boyd, Rajiv Raja,
Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions
Customized Oligonucleotide Array-Based Comparative Genomic Hybridization as a Clinical Assay for Genomic Profiling of Chronic Lymphocytic Leukemia  Rachel.
William L. Gerald, M.D., Ph.D, 1954–2008
Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence  Xiaoyu Qu, Claudio Jeldres, Lena Glaskova, Cynthia.
Multiplex Ligation-Dependent Probe Amplification Versus Multiprobe Fluorescence in Situ Hybridization To Detect Genomic Aberrations in Chronic Lymphocytic.
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Detection of Exon 12 Mutations in the JAK2 Gene
ColoSeq Provides Comprehensive Lynch and Polyposis Syndrome Mutational Analysis Using Massively Parallel Sequencing  Colin C. Pritchard, Christina Smith,
Rapid Next-Generation Sequencing Method for Prediction of Prostate Cancer Risks  Viacheslav Y. Fofanov, Kinnari Upadhyay, Alexander Pearlman, Johnny Loke,
PIK3CA Hotspot Mutation Scanning by a Novel and Highly Sensitive High-Resolution Small Amplicon Melting Analysis Method  Panagiotis A. Vorkas, Nikoleta.
Jesse L. Montgomery, Nick Rejali, Carl T. Wittwer 
Detection and Discrimination between Deletional and Non-Deletional Prader-Willi and Angelman Syndromes by Methylation-Specific PCR and Quantitative Melting.
Volume 23, Issue 1, Pages 9-22 (January 2013)
Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia 
EGFR Mutations in Lung Adenocarcinomas
Bassem A. Bejjani, Lisa G. Shaffer 
Immunoglobulin Heavy Chain Gene Analysis in Lymphomas
Microarray Gene Expression Analysis of Fixed Archival Tissue Permits Molecular Classification and Identification of Potential Therapeutic Targets in Diffuse.
Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory  Jason.
Defining Ploidy-Specific Thresholds in Array Comparative Genomic Hybridization to Improve the Sensitivity of Detection of Single Copy Alterations in Cell.
Evaluating the Effect of Unclassified Variants Identified in MMR Genes Using Phenotypic Features, Bioinformatics Prediction, and RNA Assays  Lucia Pérez-Cabornero,
Sarah E. Kerr, Cheryl B. Thomas, Stephen N. Thibodeau, Matthew J
Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement.
Suzanne D. Vernon, Elizabeth R. Unger, Mangalathu Rajeevan, Irina M
Array Comparative Genomic Hybridization Detects Chromosomal Abnormalities in Hematological Cancers That Are Not Detected by Conventional Cytogenetics 
Maria Erali, David C. Pattison, Carl T. Wittwer, Cathy A. Petti 
Rebecca L. Margraf, Rong Mao, Carl T. Wittwer 
Katy Hanlon, Lorna W. Harries, Sian Ellard, Claudius E. Rudin 
Feras M. Hantash, Arlene Rebuyon, Mei Peng, Joy B
Cecily P. Vaughn, Elaine Lyon, Wade S. Samowitz 
Statistical Treatment of Fluorescence in Situ Hybridization Validation Data to Generate Normal Reference Ranges Using Excel Functions  Allison L. Ciolino,
Jie Hu, Malini Sathanoori, Sally J. Kochmar, Urvashi Surti 
KIT Gene Deletions at the Intron 10−Exon 11 Boundary in GI Stromal Tumors  Christopher L. Corless, Laura McGreevey, Ajia Town, Arin Schroeder, Troy Bainbridge,
Mutations in CHEK2 Associated with Prostate Cancer Risk
A Complex Rearrangement in the APC Gene Uncovered by Multiplex Ligation- Dependent Probe Amplification  Constanze Pagenstecher, Dorothea Gadzicki, Dietlinde.
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification 
Integrated analysis of gene expression and copy number alterations.
Presentation transcript:

Detection of TMPRSS2-ERG Translocations in Human Prostate Cancer by Expression Profiling Using GeneChip Human Exon 1.0 ST Arrays  Sameer Jhavar, Alison Reid, Jeremy Clark, Zsofia Kote-Jarai, Timothy Christmas, Alan Thompson, Christopher Woodhouse, Christopher Ogden, Cyril Fisher, Cathy Corbishley, Johann De-Bono, Rosalind Eeles, Daniel Brewer, Colin Cooper  The Journal of Molecular Diagnostics  Volume 10, Issue 1, Pages 50-57 (January 2008) DOI: 10.2353/jmoldx.2008.070085 Copyright © 2008 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 1 Expression data for ERG exons 2 to 11 in prostate cancers determined using GeneChip Human Exon 1.0 ST arrays. Cancers scored as having altered ERG expression profiles based on the statistical analyses presented in Table 1 are marked with an asterisk. In cancers designated as having altered ERG expression profiles, exon 8 of ERG was always expressed at lower levels than exons 4 to 7 and exons 9 to 11, indicating that this exon can be spliced out in rearranged ERG transcripts. In many of the cancers without altered ERG expression profiles, exon 7 was expressed at lower levels than exons 2 to 6 and exons 8 to 11, consistent with the presence of splice variants containing deletion of this 81-bp exon. The apparently depressed level of expression observed in some cancers (eg, PRC9) reflects the variation in observed level of ERG expression across the 27 cancers observed in this study, as illustrated in Figure 3, and was not believed to reflect an abnormal ERG expression pattern. For each probe set within an exon, the log2 ratio of the expression observed in the cancer to that observed in control non-neoplastic prostate epithelium was calculated. For each exon, the black dot represents the median of these values. The Journal of Molecular Diagnostics 2008 10, 50-57DOI: (10.2353/jmoldx.2008.070085) Copyright © 2008 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 2 Structure of ERG and TMPRSS2:ERG transcripts. Sequences derived from TMPRSS2 are shown in blue; sequences derived from ERG are shown in red. Light color, untranslated regions; heavy color, open reading frames predicted by tools available at http://www.dnalc.org/bioinformatics/dnalc_nucleotide_analyzer.htm#translator. The figure shows alternatively spliced variants of the normal ERG transcripts [ERG and ERG (−7)] and of the TMPRSS2:ERG hybrid transcripts [T1-E4 and T1-E4(−8)]. The spicing out of the 81-bp exon 7 (−7) in normal ERG transcripts and of the 72-bp exon 8 (−8) in TMPRSS2:ERG hybrid transcripts is predicted to occur in some prostate cancers based on the results of exon expression profiling (Figure 1). The figure also shows the predicted structure of the T1-E2 TMPRSS2:ERG hybrid transcript. Expression data were only available for ERG exons 2 to 11; exon 1 was assumed to be present in the normal ERG transcripts. The Journal of Molecular Diagnostics 2008 10, 50-57DOI: (10.2353/jmoldx.2008.070085) Copyright © 2008 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 3 Expression levels of the ERG gene. Right: Institute of Cancer Research: expression data from exons 4 to 11 of the ERG gene from 27 cancers determined in the current study using GeneChip Human Exon 1.0 ST arrays. Samples were designated as ERG rearrangement-positive (red dots) or ERG rearrangement-negative (blue dots) based on the presence of an altered ERG expression profile (see Figure 1). Cancer PRC25, which had a statistically significant elevated expression of exons 2 to 11, is marked. Left: Stephenson et al12: expression data for the ERG gene determined using Affymetrix U133A human gene array as described previously. Data from each separate cancer sample is presented a black dot. The Stephenson dataset was normalized to our data by altering the complete expression distribution (including all genes and samples) such that the mean and variance were the same as those of the Institute of Cancer Research dataset. The Journal of Molecular Diagnostics 2008 10, 50-57DOI: (10.2353/jmoldx.2008.070085) Copyright © 2008 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions